Molecular diagnosis of inheritable neuromuscular disorders. Part I: Genetic determinants of inherited disease and their laboratory detection

被引:2
作者
Greenberg, SA [1 ]
Walsh, RJ [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol,Div Neuromuscular Dis, Boston, MA 02115 USA
关键词
genetics; genetic testing; myopathy; neuromuscular disease; neuropathy;
D O I
10.1002/mus.20278
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Understanding of the genetic basis of inheritable neuromuscular disorders has grown rapidly over the last decade, resulting in improved classification and understanding of their pathogenesis. A consequence of these advances has been the development of genetic tests of blood specimens for the diagnosis of many of these diseases. For many patients, these blood tests have eliminated the need for other more invasive diagnostic tests such as muscle or nerve biopsy, and for some patients, reduced exposure to immunosuppressive medication and its complications. The first part of this review focuses on the nature of genetic disorders, the laboratory methods used in the performance of genetic tests, and general practical aspects of their use and interpretation. The second part discusses the applicability of these tests to the range of neuromuscular disorders.
引用
收藏
页码:418 / 430
页数:13
相关论文
共 69 条
[1]   Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V [J].
Antonellis, A ;
Ellsworth, RE ;
Sambuughin, N ;
Puls, I ;
Abel, A ;
Lee-Lin, SQ ;
Jordanova, A ;
Kremensky, I ;
Christodoulou, K ;
Middleton, LT ;
Sivakumar, K ;
Ionasescu, V ;
Funalot, B ;
Vance, JM ;
Goldfarb, LG ;
Fischbeck, KH ;
Green, ED .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1293-1299
[2]   The detection of large deletions or duplications in genomic DNA [J].
Armour, JAL ;
Barton, DE ;
Cockburn, DJ ;
Taylor, GR .
HUMAN MUTATION, 2002, 20 (05) :325-337
[3]  
*ATH DIAGN, POL BILL COMM INS
[4]   Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene [J].
Azzedine, H ;
Ruberg, M ;
Ente, D ;
Gilardeau, C ;
Périé, S ;
Wechsler, B ;
Brice, A ;
LeGuern, E ;
Dubourg, O .
NEUROMUSCULAR DISORDERS, 2003, 13 (04) :341-346
[5]   Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing [J].
Bennett, Richard R. ;
den Dunnen, Johan ;
O'Brien, Kristine F. ;
Darras, Basil T. ;
Kunkel, Louis M. .
BMC GENETICS, 2001, 2 (1)
[6]   The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 [J].
Boeckmann, B ;
Bairoch, A ;
Apweiler, R ;
Blatter, MC ;
Estreicher, A ;
Gasteiger, E ;
Martin, MJ ;
Michoud, K ;
O'Donovan, C ;
Phan, I ;
Pilbout, S ;
Schneider, M .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :365-370
[7]   Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotype-phenotype correlation [J].
Boerkoel, CF ;
Takashima, H ;
Garcia, CA ;
Olney, RK ;
Johnson, J ;
Berry, K ;
Russo, P ;
Kennedy, S ;
Teebi, AS ;
Scavina, M ;
Williams, LL ;
Mancias, P ;
Butler, IJ ;
Krajewski, K ;
Shy, M ;
Lupski, JR .
ANNALS OF NEUROLOGY, 2002, 51 (02) :190-201
[8]  
BUNYAN DJ, 1995, HUM GENET, V95, P43
[9]  
Cannizzaro L A, 1997, Methods Mol Biol, V75, P313
[10]   Integration of cytogenetic landmarks into the draft sequence of the human genome [J].
Cheung, VG ;
Nowak, N ;
Jang, W ;
Kirsch, IR ;
Zhao, S ;
Chen, XN ;
Furey, TS ;
Kim, UJ ;
Kuo, WL ;
Olivier, M ;
Conroy, J ;
Kasprzyk, A ;
Massa, H ;
Yonescu, R ;
Sait, S ;
Thoreen, C ;
Snijders, A ;
Lemyre, E ;
Bailey, JA ;
Bruzel, A ;
Burrill, WD ;
Clegg, SM ;
Collins, S ;
Dhami, P ;
Friedman, C ;
Han, CS ;
Herrick, S ;
Lee, J ;
Ligon, AH ;
Lowry, S ;
Morley, M ;
Narasimhan, S ;
Osoegawa, K ;
Peng, Z ;
Plajzer-Frick, I ;
Quade, BJ ;
Scott, D ;
Sirotkin, K ;
Thorpe, AA ;
Gray, JW ;
Hudson, J ;
Pinkel, D ;
Ried, T ;
Rowen, L ;
Shen-Ong, GL ;
Strausberg, RL ;
Birney, E ;
Callen, DF ;
Cheng, JF ;
Cox, DR .
NATURE, 2001, 409 (6822) :953-958